Nishan Guha

发表

The detection of growth hormone and insulin-like growth factor-I misuse in athletes

Nishan Guha, 2013 .

P. Sönksen, R. Holt, Nishan Guha, 2009, Current drug abuse reviews.

Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

D. Böhning, P. Sönksen, R. Holt, 2017, Drug testing and analysis.

Isolated aortic root dilation in homocystinuria

P. Elliott, R. Lachmann, E. Murphy, 2017, Journal of Inherited Metabolic Disease.

Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection

P. Sönksen, R. Holt, D. Cowan, 2013, Analytical and Bioanalytical Chemistry.

Combined statistical decision limits based on two GH-2000 scores for the detection of growth hormone misuse

D. Böhning, F. Bretz, Wei Liu, 2022, Statistical methods in medical research.

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice

J. Poulton, M. Mirzazadeh, M. Hofer, 2017, Journal of clinical medicine.

The effects of recombinant human insulin‐like growth factor‐1/insulin‐like growth factor binding protein‐3 administration on lipid and carbohydrate metabolism in recreational athletes

D. Böhning, P. Sönksen, R. Holt, 2020, Clinical endocrinology.

Protocol for an observational study investigating hormones triggering the onset of sustained lactation: the INSIGHT study

S. Kennedy, F. Hannan, Nishan Guha, 2022, BMJ Open.

Assays for GH, IGF-I, and IGF binding protein-3.

Nishan Guha, 2013, Methods in molecular biology.

Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

P. Sönksen, I. Erotokritou-Mulligan, E. Bassett, 2013, Drug testing and analysis.

The Effects of Recombinant Human Insulin-Like Growth Factor-I/Insulin-Like Growth Factor Binding Protein-3 Administration on Body Composition and Physical Fitness in Recreational Athletes.

D. Böhning, P. Sönksen, R. Holt, 2015, The Journal of clinical endocrinology and metabolism.

Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.

P. Sönksen, I. Erotokritou-Mulligan, E. Bassett, 2010, The Journal of clinical endocrinology and metabolism.

Anabolic steroid use and ischaemic stroke in a young fitness enthusiast

J. Choulerton, Nishan Guha, R. Squires, 2021, BMJ Case Reports.

The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.

D. Böhning, P. Sönksen, E. Bassett, 2015, Drug testing and analysis.

Therapeutic drug monitoring in the era of precision medicine: opportunities!

Brian Shine, S. Cremers, B. Shine, 2016, British journal of clinical pharmacology.

Hyperandrogenism controversy in elite women’s sport: an examination and critique of recent evidence

M. Ferguson-Smith, R. Holt, P. Sőnksen, 2018, British Journal of Sports Medicine.

Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease

Robert W. Taylor, M. Moedas, J. Poulton, 2022, Human molecular genetics.

Post-pituitary surgery copeptin analysis as a ‘rule-out’ test for post-operative diabetes insipidus

S. Cudlip, B. Shine, T. James, 2022, Endocrine.

Comparison of normal distribution–based and nonparametric decision limits on the GH‐2000 score for detecting growth hormone misuse (doping) in sport

D. Böhning, F. Bretz, Wei Liu, 2020, Biometrical journal. Biometrische Zeitschrift.

The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.

P. Sönksen, I. Erotokritou-Mulligan, E. Bassett, 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.

P. Sönksen, I. Erotokritou-Mulligan, E. Bassett, 2014, The Journal of clinical endocrinology and metabolism.

IGF-I abuse in sport: current knowledge and future prospects for detection.

P. Sönksen, R. Holt, Nishan Guha, 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.

P. Sönksen, I. Erotokritou-Mulligan, E. Bassett, 2012, Drug testing and analysis.

The use of biochemical analysis for diagnosis and management

B. Shine, Nishan Guha, 2020 .

Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1.

D. Meredith, C. Boyd, D Meredith, 2000, European journal of biochemistry.

Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection

D. Böhning, Wei Liu, P. Sönksen, 2019, Statistical methods in medical research.

Why do endocrine profiles in elite athletes differ between sports?

D. Böhning, P. Sönksen, R. Holt, 2018, Clinical Diabetes and Endocrinology.

E. Bassett, Nishan Guha, C. Bartlett, 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.